General Information of Drug (ID: DMOL01E)

Drug Name
9-(4-Hydroxyphenyl)-2,7-Phenanthroline Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
447874
ChEBI ID
CHEBI:40444
TTD Drug ID
DMOL01E

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID25991433-Compound-A1 DM89LF0 N. A. N. A. Patented [2]
PMID25991433-Compound-F2 DM37VIQ N. A. N. A. Patented [2]
7-azaindole derivative 1 DMQL5B7 N. A. N. A. Patented [2]
7-azaindole derivative 5 DMV3H98 N. A. N. A. Patented [2]
PMID25991433-Compound-P6 DMNDVC9 N. A. N. A. Patented [2]
PMID25991433-Compound-J3 DM17P3F N. A. N. A. Patented [2]
PMID25991433-Compound-P1 DMD8AX6 N. A. N. A. Patented [2]
PMID25991433-Compound-O3 DMVOWS5 N. A. N. A. Patented [2]
PMID25991433-Compound-J2 DMZSOCK N. A. N. A. Patented [2]
7-azaindole derivative 3 DMQ7BV4 N. A. N. A. Patented [2]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Stress-activated protein kinase JNK3 (JNK3) TT056SO MK10_HUMAN Inhibitor [1]

References

1 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
2 c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).Expert Opin Ther Pat. 2015;25(8):849-72.